Learn how to successfully optimize bioreactor technology to help product quality, potency, impurity profiles, total cell density and titer/protein concentration (productivity), and ultimately deliver critical drugs to patients. Biologics, including cell and gene therapies, have become a hot topic in the pharmaceutical industry as their therapeutic applications expand. Challenges of developing biologic drug products include scale-up for commercial manufacturing and production at a high enough purity for effective medical applications. Thus, it is critical to examine the biomanufacturing steps that produce biologic drug products in order to optimize the process for the necessary production scale without losing quality and purity.
Read the full article on Cell & Gene Therapies.
Our expert Anthony Stewart outlines optimization for bioreactor technology >>Read More
If you would like to learn more about our full solutions visit: Click here